SAN DIEGO, Dec. 21, 2023 DMK Pharmaceuticals Corporation , a commercial stage neuro-biotech company primarily focused on developing and commercializing products for the treatment of opioid.
On Thursday, DMK Pharmaceuticals Corporation (DMK) experienced a significant increase in share price, with a 17% rise, following an announcement that the company has regained full rights to commercialize ZIMHI (naloxone).